Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.59 USD
+0.77 (3.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $25.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Anika Therapeutics Inc. [ANIK]
Reports for Purchase
Showing records 1 - 16 ( 16 total )
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for ANIK 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Hyaluronic Acid Overview and Reimbursement Changes
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
We maintain a Buy-Long-term rating, but reduce our price target from $55 to $45.
Provider: SINGULAR RESEARCH
Analyst: SPRINGER L
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Boost for Medical/ Dental/ Veterinary Companies-Protecting Americans from Tax Hikes Act of 2015 (PATH) - Highlights
Provider: G.RESEARCH, LLC
Analyst: TSAI J
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Comparative Oncology: A New Breed of Trial Set to Improve Clinical Success in Oncology
Provider: DAWSON JAMES SECURITIES, INC.
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
A FOUR STAR A PATENTVEST IP GROWTH COMPANY - 2011 BEST AND BRIGHTEST PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
Company: Anika Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
THE REGENERATIVE MEDICINE REPORT: Part I - Investment Analysis of the Regenerative Medicine Industry - Highlighting Emerging Technologies and Valuable Intellectual Property
Provider: MDB CAPITAL GROUP LLC
Analyst: HOBBIB G
|